Investing in your entry-level employees from the beginning will only continue to positively impact their future, and the ripple effect for businesses. Photo via Getty Images

With Spring Break behind us, many soon-to-be grads will be anxiously applying for their first entry-level jobs or internships; however nearly 50 percent of college graduates don’t feel qualified for entry-level positions and 20 percent feel like they lack basic skills to compete in the job market. It’s important for young professionals to have a solid foundation before the first day on the job, yet 40 percent of graduates say they only occasionally or rarely use skills they learned in college. This is scary for young professionals, and even more terrifying for businesses that are hiring entry-level employers.

Closing young professionals’ education-to-employment skills gap is crucial to the future of work, and how we go about surviving The Great Resignation. Businesses do not have the time, resources or money to teach every entry-level employee basic workforce skills, such as email etiquette and calendar management. According to Indeed, the average time employers spend training entry-level hires is around 33 hours per new employee, but shouldn’t some of the training be the universities’ jobs?

Maybe. However, over the past two years, colleges have been forced to redirect their focus to take care of students' mental health during the COVID-19 pandemic—understandable as between 80 to 90 percent of college students have experienced some mental health strains during the pandemic.

Each year, the National Association of Colleges and Employers (NACE) puts out a survey that assesses what should be taught in both internship-preparedness and career-readiness programs, to fill the gaps and upskill young professionals with the lessons they need to be learning. These core competencies were incorporated into Ampersand’s training, where young professionals are upskilled in a wide array of transferrable workforce skills that allow immediate success in new workplaces. Our 50-plus hours of curriculum was developed around NACE’s expertise, feedback from hundreds of businesses we spoke to,and my own personal frustrations of running a business for 12 years, which caused me to realize what opportunities and skills I wanted to bring to the new generation of professionals. Ampersand’s curriculum focuses on a variety of fundamental skills, such as: business structure fundamentals, interpersonal conflict resolution, combatting biases in the workplace, proactive communication, handling mental health issues and the art of constructive feedback.

One of the most appreciated courses in the Ampersand curriculum is the lesson on growth and grit mentality. According to psychology professor Angela Duckworth, the blend of passion and perseverance, aka “grit,” forecasts positive long-term success throughout someone’s life. Investing in these young professionals will not only set them up for larger success, but it will also give an equal and foundational opportunity to these youths as they begin developing their skills and growth mentalities. Mastering both basic workforce skills and goal setting allows young professionals to help them decide whether or not a job position is the right fit for them. Additionally, it will also help young professionals set up and successfully navigate five- or 10-year plans to use as bars of measurement in their future work endeavors.

In recognizing the education-to-employment skills gap and the need for excellent career-readiness training, The City of Houston’s Hire Houston Youth program has partnered with Ampersand to upskill thousands of young professionals applying for its summer jobs. Ampersand has created an exclusive curriculum for the Hire Houston Youth program that includes 35 lessons, five modules and four hours of asynchronous career-readiness content. These modules include topics such as professional development, employee rights and basic skill building. As a part of its partnership with Ampersand, Hire Houston Youth is making it mandatory for the young adults applying for a job to go through Ampersand’s platform in order to be eligible for an interview. With the partnership between Ampersand and Hire Houston Youth, the next generation of Houstonians will have a sharp set of career-readiness skills and be able to hit the ground running in any future job.

By recognizing and focusing on these necessary skills early on, while also providing a space for these young professionals to learn and grow, the new generation will have more opportunities and doors open up for them as they begin their careers. Investing in them from the beginning will only continue to positively impact their future, and the ripple effect for businesses.

------

Allie Danziger is the co-founder and CEO of Houston-based Ampersand Professionals.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”